Hofseth Biocare ASA: PRIMARY INSIDER NOTIFICATION
Hofseth BioCare ASA (HBC) · publisert 2023-02-17 07:00 · vis på NewsWeb
Transaksjoner
| Person | Rolle | Type | Volum | Pris | Dato | ISIN | Handelsplass | Tolket via |
|---|---|---|---|---|---|---|---|---|
| Christoph Baldegger | Board member in Hofseth Biocare ASA | acquisition | 272 000 | 100 000 NOK | 2023-02-16 | – | Oslo Stock Exchange, main list | rules |
Vedlegg
- PDMR notification form - Christoph Baldegger.pdf (tekst hentet ut)
Meldingstekst
Christoph Baldegger, primary insider and member of the board of directors in
Hofseth BioCare ASA ("HBC") has today purchased 100,000 shares in HBC at an
average price of NOK 2.72 per share. As a result of the transaction, Mr.
Baldegger holds 800,000 shares in HBC, equal to approximately 0.20 % of the
outstanding shares.
Please see the attached notification form for further information.
Jon Olav Ødegård, CEO of Hofseth BioCare ASA
Phone: +47 936 32 966
E-mail: joo@hofsethbiocare.no
This information is subject to the disclosure requirements in the Market Abuse
Regulation EU 596/2014 article 19 number 3 and the Norwegian Securities Trading
Act section 5-12.